This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

GlaxoSmithKline PLC (GSK)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 9.13B 6.76B 8.87B 9.35B
Receivables 8.71B 8.64B 8.79B 9.03B
Inventories 6.43B 6.41B 6.01B 5.92B
Other Current Assets 257.24M 182.61M 1.14B 24.69M
Total Current Assets 25.11B 22.13B 25.10B 24.75B
Property, Plant & Equipment, Gross 31.09B 30.29B 29.24B 29.16B
Accumulated Depreciation & Depletion 16.46B 16.11B 15.66B 15.20B
Property, Plant & Equipment, Net 14.63B 14.18B 13.58B 13.96B
Intangibles 15.31B 16.42B 12.11B 13.17B
Other Non-Current Assets 3.98B 3.40B 2.73B 3.77B
Total Non-Current Assets 44.29B 44.90B 38.68B 40.43B
Liabilities & Shareholder Equity
Total Assets 69.40B 67.02B 63.78B 65.18B
Accounts Payable 8.83B 13.02B 11.43B 10.63B
Short Term Debt 4.60B 5.87B 4.19B 449.13M
Other Current Liabilities 4.24B 3.44B 7.69B 8.67B
Total Current Liabilities 22.55B 22.33B 23.30B 19.75B
Long Term Debt 25.49B 23.71B 18.95B 22.86B
Deferred Income Taxes 1.14B 1.62B 1.28B 1.09B
Other Non-Current Liabilities 7.33B 8.46B 6.55B 6.44B
Minority Interest 316.61M 289.26M 305.86M 338.00M
Total Non-Current Liabilities 35.31B 35.31B 28.01B 31.72B
Total Liabilities 57.86B 57.63B 51.31B 51.46B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 11.54B 9.39B 12.47B 13.72B
Common Par 2.20B 2.18B 2.15B 2.19B
Additional Paid In Capital 4.28B 3.27B 2.60B 2.20B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 1.51B 1.05B 5.23B 7.38B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 3.55B 2.89B 2.49B 1.95B
Total Capitalization 37.02B 33.10B 31.42B 36.57B
Total Equity 11.54B 9.39B 12.47B 13.72B
Total Liabilities & Stock Equity 69.40B 67.02B 63.78B 65.18B
Total Common Shares Outstanding 2.43B 2.45B 2.52B 2.60B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 487.43M 494.95M 501.20M 474.19M
Basic Weighted Shares Outstanding 2.42B 2.46B 2.51B 2.54B
Diluted Weighted Shares Outstanding 2.46B 2.49B 2.56B 2.56B
Number of Employees 99451 99488 97389 96461
Number of Part-Time Employees 0 0 0 0
GSK News

GSK GlaxoSmithKline PLC

Analysts Ratings for GSK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 4 5 6 6
Moderate Sell 1 1 0 0
Strong Sell 1 1 1 1

Brokerage Partners

GSK Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs